INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Most active filers · 30d

  1. 01FWFogarty Patrick W0B / 206S206 trades$1.10M
  2. 02Kurtz George0B / 202S202 trades$48.06M
  3. 03SPSaba Capital Management, L.P.67B / 19S · 11 late86 trades$21.51M
  4. 04NYNissan Yitzhak82B / 0S · 79 late82 trades$2.61M
  5. 05ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  6. 06AJAllaire Jeremy0B / 50S50 trades$4.26M
  7. 07Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  8. 08SJSheena Jonathan0B / 45S45 trades$3.01M
  9. 09SISarowitz Steven I2B / 34S36 trades$21.18M
  10. 10SLSpeiser Michael L0B / 35S35 trades$14.00M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 1732 insiders$917K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 179 insiders$893K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 168 insiders$42.58M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLMGNIMAGNITE, INC.Nov 5 – Nov 178 insiders$2.77M
  7. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  8. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M

Form 4 transactions

73,372 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
12
OA
Ortiz Mauricio AEVP & Chief Accounting Officer
CMACOMERICA INC
Option exercise
M$56K
925 sh
Jan 22, 2026Jan 23, 2026
Page 1457 of 1835
← PrevNext →
traded Jan 22, 2026
+1d
SEC Form 4

Evidence

12
EA
Eidson Charles AndrewDirector, Chief Executive Officer
AMRAlpha Metallurgical Resources, Inc.
Tax withholding
F$207K
882 sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

12
LD
Lail Crystal DawnVP and CFO
NWENorthWestern Energy Group, Inc.
Tax withholding
F$52K
808 sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

12
WE
Whitehead Jason E.President & COO
AMRAlpha Metallurgical Resources, Inc.
Tax withholding
F$146K
623 sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

12
HE
Horn Daniel E.Chief Commercial Officer
AMRAlpha Metallurgical Resources, Inc.
Tax withholding
F$96K
407 sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

12
HC
Hoyt CaseyDirector, Chief Executive Officer
VMDVIEMED HEALTHCARE, INC.
Tax withholding
F$102K
13.6K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

12
AB
Alexander Victor BHead of Consumer Bank
KEYKEYCORP /NEW/
Tax withholding
F$135K
6,236 sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

12
WH
Weber James HarryExecutive Vice President
CMACOMERICA INC
Option exercise
M$67K
940 sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

12
HC
Hoyt CaseyDirector, Chief Executive Officer
VMDVIEMED HEALTHCARE, INC.
Disposition to issuer
D$93K
12.4K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

12
HW
Hanna John Walter JRDirector, President and CEO
CDNACareDx, Inc.
Open-market sale · 10b5-1 plan
SELL$408K
19.3K sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

12
EB
Edris BadreddinDirector
EWTXEdgewise Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$224K
7,605 sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

11
EB
Edris BadreddinDirector
EWTXEdgewise Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$5,339
13.7K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

11
GH
Gan HongCHIEF SCIENCE OFFICER
SESSES AI Corp
Open-market sale · 10b5-1 plan
SELL$250K
100.0K sh
Jan 23, 2026Jan 23, 2026
traded Jan 23, 2026
+0dSEC Form 4

Evidence

11
GE
Gilliam Joseph EPRESIDENT & COO
GKOSGLAUKOS Corp
Open-market sale · 10b5-1 plan
SELL$561K
4,502 sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

11
GH
Gan HongCHIEF SCIENCE OFFICER
SESSES AI Corp
Open-market sale · 10b5-1 plan
SELL$374K
150.0K sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

11
EB
Edris BadreddinDirector
EWTXEdgewise Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$11K
17.2K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

11
KP
Kirol Charles PeterChief Operating Officer
PTONPELOTON INTERACTIVE, INC.
Open-market sale · 10b5-1 plan
SELL$20K
3,399 sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

11
SH
Schingler Robert HDirector, Co-Founder Chief Strategy Off.
PLPlanet Labs PBC
Tax withholding
F$488K
18.5K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

9
HG
Harrison GilbertDirector
IPARINTERPARFUMS INC
Option exercise
M—
375 sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

9
OA
Ortiz Mauricio AEVP & Chief Accounting Officer
CMACOMERICA INC
Option exercise
M—
815 sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

9
OA
Ortiz Mauricio AEVP & Chief Accounting Officer
CMACOMERICA INC
Option exercise
M$44K
650 sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

9
BM
Brennan Ita MDirector
PLPlanet Labs PBC
Option exercise
M—
423 sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

9
FW
Frazier WilliamDirector, Chief Medical Officer
VMDVIEMED HEALTHCARE, INC.
Option exercise
M—
3,401 sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

9
SI
Stefan Constantin IonelChief Technology Officer
AMPXAmprius Technologies, Inc.
Option exercise
M—
15.9K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

9
SI
Stefan Constantin IonelChief Technology Officer
AMPXAmprius Technologies, Inc.
Option exercise
M—
15.8K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

9
FW
Frazier WilliamDirector, Chief Medical Officer
VMDVIEMED HEALTHCARE, INC.
Tax withholding
F$8,756
1,169 sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

9
DD
Dillard George Douglas JrDirector
AYIACUITY INC. (DE)
Grant or award
A—
546 sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

9
WH
Weber James HarryExecutive Vice President
CMACOMERICA INC
Option exercise
M$29K
543 sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

9
HC
Hirano Patricia CSEE REMARKS
SLNOSOLENO THERAPEUTICS INC
Grant or award
A—
11.9K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

9
YS
Yurasov SergeyCHIEF MEDICAL OFFICER
BDTXBlack Diamond Therapeutics, Inc.
Grant or award
A—
250.0K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

9
TK
Tracey KevinDirector
UTHRUNITED THERAPEUTICS Corp
Grant or award
A—
1,220 sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

9
WC
Wiese ChristopherPresident, Energy Vault Labs
NRGVEnergy Vault Holdings, Inc.
Tax withholding
F$31K
6,808 sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

9
FW
Frazier WilliamDirector, Chief Medical Officer
VMDVIEMED HEALTHCARE, INC.
Option exercise
M—
850 sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

9
AB
Alexander Victor BHead of Consumer Bank
KEYKEYCORP /NEW/
Option exercise
M—
9,345 sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

9
TD
Townsell DonnaDirector, Director of Investor Relations
HOMBHOME BANCSHARES INC
Option exercise
M—
20.0K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

9
WH
Weber James HarryExecutive Vice President
CMACOMERICA INC
Option exercise
M—
1,335 sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

9
SL
Spikner Pamela L.SVP Controller & CAO
BDXBECTON DICKINSON & CO
Tax withholding
F—
84 sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

9
SB
Streeter Jeffrey BDirector
CHMGCHEMUNG FINANCIAL CORP
Grant or award
A$33K
574 sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

9
CM
Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$421K
3,350 sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

9
BR
Bensoussan Torres RobertDirector
IPARINTERPARFUMS INC
Option exercise
M—
375 sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence